The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic

Applied Microbiology and Biotechnology

Volumn 95, Issue 1, 2012, Pages 113-122

  Tóth, Viktória ^a   Nagy, Csilla Terézia ^a   Pócsi, István ^a   Emri, Tamás ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Aspergillus nidulans var. roseus; Chitin synthesis; Echinocandin resistance; Emericella rugulosa; Paradoxical growth

Indexed keywords

ANTIMYCOTICS; ASPERGILLUS NIDULANS; CATALYTIC SUBUNITS; CELL WALLS; ECHINOCANDIN; EMERICELLA RUGULOSA; GLUCAN CONTENT; IN-VIVO; LIPOPEPTIDES; PHYSIOLOGICAL EFFECTS; REDUCED GROWTH RATE; SYNTHASES;

ASPERGILLUS; BIOCHEMISTRY; BIOSYNTHESIS; CELL CULTURE; CHITIN; MACHINERY;

VALUE ENGINEERING;

1,3 BETA GLUCAN SYNTHASE; ANTIFUNGAL AGENT; BETA GLUCAN; CHITIN; ECHINOCANDIN B; LIPOPEPTIDE;

BIOASSAY; CELL ORGANELLE; CHITIN; CONCENTRATION (COMPOSITION); DEVELOPMENTAL BIOLOGY; FUNGUS; GENE EXPRESSION; LIPID; MACHINERY; MUTATION; PEPTIDE;

ARTICLE; ASPERGILLUS NIDULANS; ASPERGILLUS NIDULANS ROSEUS; CELL WALL; EMERICELLA; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SUBUNIT; FUNGAL STRAIN; FUNGUS CULTURE; GENE EXPRESSION; GENETIC CODE; GROWTH RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; STRAIN DIFFERENCE; UPREGULATION;

ANTIFUNGAL AGENTS; ASPERGILLUS NIDULANS; BETA-GLUCANS; BIOTECHNOLOGY; CHITIN; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FUNGAL PROTEINS; GLUCOSYLTRANSFERASES; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS;

EMERICELLA NIDULANS; EMERICELLA RUGULOSA; FUNGI;

EID: 84862022383     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4027-y     Document Type: Article

References (35)

1. Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, Lars-Flörl C (2008) Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 52:3504-3511
2. Arendrup MC, Garcia-Effron G, Buzina W, Mortensen KL, Reiter N, Lundin C, Jensen HE, Lass-Flörl C, Perlin DS, Bruun B (2009) Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother 53:1185-1193
3. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH (2001) In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 45:327-330 (Pubitemid 32039139)
4. Barratt RW, Johnson GB, Ogata WN (1965) Wildtype and mutant stocks of Aspergillus nidulans. Genetics 52:233-246
5. Boeck LD, Kastner RE (1981) Method of producing the A-30912 antibiotics. U.S. Patent 4,288,549
6. Borgia PT, Dodge CL (1992) Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan. J Bacteriol 174:377-383
7. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-536
8. Denning DW (2002) Echinocandins: a new class of antifungal. J Antimicrob Chemother 49:889-891
9. Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA (2003) Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41:3623-3626 (Pubitemid 36994692)
10. Fabrizio P, Battistella L, Vardavas R, Gattazzo C, Liou LL, Diaspro A, Dossen JW, Gralla EB, Longo VD (2004) Superoxide is a mediator of an altruistic aging program in Saccharomyces cerevisiae. J Cell Biol 166:1055-1067 (Pubitemid 39304768)
11. Fekete A, Emri T, Gyetvai Á, Gazdag Z, Pesti M, Varga Z, Balla J, Cserháti C, Emo{combining double acute accent}dy L, Gergely L, Pócsi I (2007) Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans. FEMS Yeast Res 7:834-847
12. Fekete A, Pócsi I, Emri T, Gyetvai Á, Gazdag Z, Pesti M, Karányi Z, Majoros L, Gergely L, Pócsi I (2008) Physiological and morphological characterization of tert-butylhydroperoxide tolerant Candida albicans mutants. J Basic Microbiol 48:480-487
13. Galgóczy L, Papp T, Leiter É, Marx F, Pócsi I, Vágvölgyi C (2005) Sensitivity of different Zygomycetes to the Penicillium chrysogenum antifungal protein (PAF). J Basic Microbiol 45:136-141
14. Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS (2008) A naturally-occurring Fks1p proline to alanine amino acid change in Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52:2305-2312 (Pubitemid 351915657)
15. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS (2009) Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53:3690-3699
16. Gardiner RE, Souteropoulos P, Park S, Perlin DS (2005) Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Med Mycol 43:S299-S305 (Pubitemid 41038582)
17. Ha YS, Covert SF, Momany M (2006) FsFKS1, the 1,3-β-glucan synthase from the caspofungin-resistant fungus Fusarium solani. Eukaryot Cell 5:1036-1042 (Pubitemid 44100702)
18. Howard SJ, Arendrup MC (2011) Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 49:S90-S95
19. Klich M, Mendoza C, Mullaney E, Keller N, Bennett JW (2001) A new sterigmatocystin-producing Emericella variant from agricultural desert soils. Syst Appl Microbiol 24:131-138 (Pubitemid 32433702)
20. Lewis RE, Albert ND, Kontoyiannis DP (2008) Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J Antimicrob Chemother 61:1140-1144 (Pubitemid 351524462)
21. McCluskey K (2003) The Fungal Genetics Stock Center, from molds to molecules. Adv Appl Microbiol 52:245-262
22. Moreno AB, del Pozo AM, Borja M, San Segudo B (2003) Activity of the antifungal protein from Aspergillus giganteus against Botrytis cinerea. Phytopathology 93:1344-1353
23. Ouedraogo JP, Hagen S, Spielvogel A, Engelhardt S, Meyer V (2011) Survival strategies of yeast and filamentous fungi against the antifungal protein AFP. J Biol Chem 286:13859-13868
24. Pacetti SA, Gelone SP (2003) Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother 37:90-98 (Pubitemid 36068607)
25. Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, LiW, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS (2005) Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49:3264-3273 (Pubitemid 41060570)
26. Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updates 10:121-130
27. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ (2003) Caspofungin activity against clinical isolates of fluconazole- resistant Candida. J Clin Microbiol 41:5729-5731 (Pubitemid 37543273)
28. Plaine A, Walker L, Da Costa G, Mora-Montes HM, McKinnon A, Gow NA, Gaillardin C, Munro CA, Richard ML (2008) Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol 45:1404-1414
29. Pócsi I, Leiter É, Kwon NJ, Shin KS, Kwon GS, Pusztahelyi T, Emri T, Abuknesha R, Price R, Yu JH (2009) Asexual sporulation signaling regulates autolysis of Aspergillus nidulans via modulating the chitinase ChiB production. J Appl Microbiol 107:514-523
30. Pusztahelyi T, Molnár Z, Emri T, Klement É, Miskei M, Kerékgyártó J, Balla J, Pócsi I (2006) Comparative studies on differential expression of chitinolytic enzymes encoded by chiA, chiB, chiC and nagA genes in Aspergillus nidulans. Folia Microbiol 51:547-554
31. Shedletzky E, Unger C, Delmer DP (1997) A microtiter-based fluorescence assay for (1,3)-β-glucan synthases. Anal Biochem 249:88-93 (Pubitemid 27251947)
32. Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H (2006) Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for β-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 50:3160-3161 (Pubitemid 44396427)
33. Tóth V, Nagy CT, Miskei M, Pócsi I, Emri T (2011) Polyphasic characterization of "Aspergillus nidulans var. roseus" ATCC 58397. Folia Microbiol 56:381-388
34. Walker LA, Gow NAR, Munro CA (2010) Fungal echinocandin resistance. Fungal Genet Biol 47:117-126
35. Wiederhold NP (2009) Paradoxical echinocandin activity: a limited in vitro phenomenon? Med Mycol 47(Suppl 1)S369-S375